Heart and Vascular Who should be screened? ▪ 40+ years old ▪ If you smoke /are around second-hand smoke ▪ If you are diabetic ▪ If you have a family history of heart disease, stroke, aneurysm ▪ If you are overweight ▪ If you have high blood pressure ▪ If you have had any previous heart conditions
Cancer Who should be screened? While anyone can be at risk for Cancer below are some common risk factors • Age • Alcohol • Cancer causing substances • Chronic Inflammation • Diet • Family History • Hormones • Sunlight • Tobacco • Immunosuppression
HEART & VASCULAR AND CANCER SCREENING PERFORMED VIA ULTRASOUND 25 MINUTES PAIN-FREE INTERACTIVE EASY IMMEDIATE FEEDBACK
We’ve Got It Covered… Step 1 Employee Education Marketing Tools ▪ Pre-Screening Education ▪ Registration/Scheduling Step 2 ▪ Follow-up Online Scheduling Flexibility & Support Step 3 Abnormal Referrals Executive Summary
Executive Summary Example
My Story and Demo
10/10/2015 Peripheral Vascular Disease Ganesh Muthappan, MD, FACC
Vascular Surgery Headline Surgical Treatments of Swedish Heart &
Gill Heart and Vascular Institute Affiliate Network: 2018 Update Gill Heart
Pulmonary Vascular Changes in Pulmonary Vascular Changes in Heart Disease
4/16/2016 Anatomic Staging for Chronic Limb Disclosures Threatening Ischemia
. Hypertension Ivan Anderson, MD Cardiologist Renown Institute for Heart
Revolutionary Monitoring Technology for Vascular Health SIMPLE | NON-INVASIVE
Most Important Clinical Trials of the Past Decade in Vascular Intervention
What Are My Treatment Options for AF? Mikhael El-Chami, MD FACC, FHRS Emory
4/7/2017 Disclosure Optimizing The Performance Of None Your Vascular Lab
7 th Vascular Biomechanics Society Does Arterial Stiffness Contribute to
EKG & Vital Signs Training for Clinical Research Coordinators CCI Nursing
Kimberly D. Thomas, DNP, ARNP, CWCN-AP, COCN Advanced Registered Nurse
Poster Presentation Day 1 (April 12 th , 2019) Name Poster Title Code
Healthcare without boundaries EMIS Group plc 2012 results presentation Mike
A Next Generation Stem Cell Therapeutics Company Cynata Therapeutics Limited
Brain lateralization and the emergence of language Nathalie TZOURIO-MAZOYER
The Shoulder By: Jess Feinberg, Nick Williams, Matt Drum & Eric Beer
BELGIUM 27th !!! 1) HTA DE GRADE 3 = TOUJOURS RISQUE > ELEVE 4 3 2)
Research Article
MANAGEMENT OF SPINAL DEFORMITIES IN ANKYLOSING SPONDYLITIS DR. RAJESH
Tumor Necrosis Factor- Inhibitor ( TNFi) utilization among women with live